Table 1.
Study | Cell Type | Intervention | Results |
---|---|---|---|
Chiesi et al. [42] |
Caco-2 cells stimulated with alternariol |
EVOO extract, Oleuropein, Tyrosol |
↓ ROS ↓ cytotoxicity |
Muto et al. [43] |
Caco-2 cells stimulated with LPS or IL-1β | EVOO phenolic extract | ↓ IL-8 expression and secretion |
Serelli et al. [44] |
Caco-2 cells treated with LPS | HT and Tyr metabolites | ↓ degradation of IĸBα ↓ iNOS expression |
Di Nunzio et al. [45] |
Caco-2 cells treated with IL-1β | Polyphenols sourced from olive pomace | ↓ IL-8 |
Incani et al. [46] |
Caco-2 cells treated with tert-butyl hydroperoxide (TBH) or a mixture of oxysterols | Preincubation with the phenolic extracts | ↓ ROS |
Borges et al. [47] |
Caco-2 cell cultures | Six Spanish monovarietal EVOOs (EVOOs’ bioaccessible fractions (BF) after in vitro digestion | ↑ phenolic count and anti-oxidant activity ↓ ROS |
Gill et al. [48] |
In vitro model of colon carcinogenesis (HT-29 cells treated with hydrogen peroxide, Caco-2 cells, HT115 cells) | EVOO phenols | anti-genotoxic effect ↑ barrier function in Caco-2 cells ↓ HT115 cell invasion and attachment |
Larrussa et al. [51] |
Ex vivo organ culture of mucosal explants from UC patients | Oleuropein | ↓ COX 2 and IL-17 expression ↓ infiltration of CD3, CD 4 and CD20 cells ↑ mucosal healing |
Vezza et al. [52] |
Ex vivo colon cultures from CD patients, DSS and DNBS mice colitis models | Olive leaf extract | ↓ expression of IL-1β, TNF-α, and iNOS ↑ epithelial barrier (ZO-1, MUC-2, and TFF-3) |
Abbreviations: EVOO: extra-virgin olive oil, ROS: reactive oxygen species, IĸBα: inhibitor of ĸappa Bα, iNOS: inducible nitric-oxide synthetase, IL-8: interleukin 8, IL-17: interleukin 17, TNF-α: tumour necrosis factor alpha, COX 2: cyclooxygenase 2, ZO-1: zonula occludes protein 1, MUC-2: mucin 2, TFF-3: intestinal trefoil factor, ↓ = decrease in, ↑ = increase in.